Influence of PCL molecular weight on mesenchymal stromal cell differentiation

W.J. Hendrikson, Jeroen Rouwkema, Clemens van Blitterswijk, Lorenzo Moroni

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
24 Downloads (Pure)

Abstract

Regenerating or replacing bone, chondral and osteochondral defects, is an active field in tissue engineering. A general strategy is to use a temporary scaffold in which cells are seeded onto the scaffold prior to implantation or attracted into the scaffold from surrounding tissues in the implantation site to form the desired tissue. Several biomaterials have been used for the fabrication of scaffolds, including polycaprolactone (PCL) which is often used for musculoskeletal tissue engineering. The effect of the PCL scaffold architecture on the cell behavior has been investigated. However, the mechanical properties of the bulk material were not taken into account in these studies. PCL is available in a range of molecular weights, resulting in a range of bulk mechanical properties. Since bulk material stiffness is able to direct cell differentiation, it is likely that the molecular weight of PCL may influence cell behavior. Here, we investigated the bulk material properties of both low and high molecular weight PCL scaffolds fabricated through additive manufacturing. The low molecular weight PCL showed a lower bulk material stiffness. During in vitro cell culture, this resulted in a stronger tendency for hypertrophic chondrogenic differentiation compared to the high molecular weight PCL. This study shows that apart from the polymer chemistry and scaffold architecture, the bulk mechanical properties of the polymer used is an important parameter in scaffold fabrication. This is an important finding for the optimization of osteochondral tissue engineering
Original languageEnglish
Pages (from-to)54510-54516
Number of pages7
JournalRSC advances
Volume5
DOIs
Publication statusPublished - 2015

Fingerprint

Polycaprolactone
Scaffolds
Molecular weight
Tissue engineering
Mechanical properties
Polymers
3D printers
Stiffness
Tissue
Fabrication
Biocompatible Materials
Scaffolds (biology)
polycaprolactone
Cell culture
Biomaterials
Materials properties
Bone
Defects

Keywords

  • METIS-310786
  • IR-96691

Cite this

Hendrikson, W.J. ; Rouwkema, Jeroen ; van Blitterswijk, Clemens ; Moroni, Lorenzo. / Influence of PCL molecular weight on mesenchymal stromal cell differentiation. In: RSC advances. 2015 ; Vol. 5. pp. 54510-54516.
@article{f5236660ef4e4b03a5f83d23f031314a,
title = "Influence of PCL molecular weight on mesenchymal stromal cell differentiation",
abstract = "Regenerating or replacing bone, chondral and osteochondral defects, is an active field in tissue engineering. A general strategy is to use a temporary scaffold in which cells are seeded onto the scaffold prior to implantation or attracted into the scaffold from surrounding tissues in the implantation site to form the desired tissue. Several biomaterials have been used for the fabrication of scaffolds, including polycaprolactone (PCL) which is often used for musculoskeletal tissue engineering. The effect of the PCL scaffold architecture on the cell behavior has been investigated. However, the mechanical properties of the bulk material were not taken into account in these studies. PCL is available in a range of molecular weights, resulting in a range of bulk mechanical properties. Since bulk material stiffness is able to direct cell differentiation, it is likely that the molecular weight of PCL may influence cell behavior. Here, we investigated the bulk material properties of both low and high molecular weight PCL scaffolds fabricated through additive manufacturing. The low molecular weight PCL showed a lower bulk material stiffness. During in vitro cell culture, this resulted in a stronger tendency for hypertrophic chondrogenic differentiation compared to the high molecular weight PCL. This study shows that apart from the polymer chemistry and scaffold architecture, the bulk mechanical properties of the polymer used is an important parameter in scaffold fabrication. This is an important finding for the optimization of osteochondral tissue engineering",
keywords = "METIS-310786, IR-96691",
author = "W.J. Hendrikson and Jeroen Rouwkema and {van Blitterswijk}, Clemens and Lorenzo Moroni",
year = "2015",
doi = "10.1039/c5ra08048g",
language = "English",
volume = "5",
pages = "54510--54516",
journal = "RSC advances",
issn = "2046-2069",
publisher = "Royal Society of Chemistry",

}

Influence of PCL molecular weight on mesenchymal stromal cell differentiation. / Hendrikson, W.J.; Rouwkema, Jeroen; van Blitterswijk, Clemens; Moroni, Lorenzo.

In: RSC advances, Vol. 5, 2015, p. 54510-54516.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Influence of PCL molecular weight on mesenchymal stromal cell differentiation

AU - Hendrikson, W.J.

AU - Rouwkema, Jeroen

AU - van Blitterswijk, Clemens

AU - Moroni, Lorenzo

PY - 2015

Y1 - 2015

N2 - Regenerating or replacing bone, chondral and osteochondral defects, is an active field in tissue engineering. A general strategy is to use a temporary scaffold in which cells are seeded onto the scaffold prior to implantation or attracted into the scaffold from surrounding tissues in the implantation site to form the desired tissue. Several biomaterials have been used for the fabrication of scaffolds, including polycaprolactone (PCL) which is often used for musculoskeletal tissue engineering. The effect of the PCL scaffold architecture on the cell behavior has been investigated. However, the mechanical properties of the bulk material were not taken into account in these studies. PCL is available in a range of molecular weights, resulting in a range of bulk mechanical properties. Since bulk material stiffness is able to direct cell differentiation, it is likely that the molecular weight of PCL may influence cell behavior. Here, we investigated the bulk material properties of both low and high molecular weight PCL scaffolds fabricated through additive manufacturing. The low molecular weight PCL showed a lower bulk material stiffness. During in vitro cell culture, this resulted in a stronger tendency for hypertrophic chondrogenic differentiation compared to the high molecular weight PCL. This study shows that apart from the polymer chemistry and scaffold architecture, the bulk mechanical properties of the polymer used is an important parameter in scaffold fabrication. This is an important finding for the optimization of osteochondral tissue engineering

AB - Regenerating or replacing bone, chondral and osteochondral defects, is an active field in tissue engineering. A general strategy is to use a temporary scaffold in which cells are seeded onto the scaffold prior to implantation or attracted into the scaffold from surrounding tissues in the implantation site to form the desired tissue. Several biomaterials have been used for the fabrication of scaffolds, including polycaprolactone (PCL) which is often used for musculoskeletal tissue engineering. The effect of the PCL scaffold architecture on the cell behavior has been investigated. However, the mechanical properties of the bulk material were not taken into account in these studies. PCL is available in a range of molecular weights, resulting in a range of bulk mechanical properties. Since bulk material stiffness is able to direct cell differentiation, it is likely that the molecular weight of PCL may influence cell behavior. Here, we investigated the bulk material properties of both low and high molecular weight PCL scaffolds fabricated through additive manufacturing. The low molecular weight PCL showed a lower bulk material stiffness. During in vitro cell culture, this resulted in a stronger tendency for hypertrophic chondrogenic differentiation compared to the high molecular weight PCL. This study shows that apart from the polymer chemistry and scaffold architecture, the bulk mechanical properties of the polymer used is an important parameter in scaffold fabrication. This is an important finding for the optimization of osteochondral tissue engineering

KW - METIS-310786

KW - IR-96691

U2 - 10.1039/c5ra08048g

DO - 10.1039/c5ra08048g

M3 - Article

VL - 5

SP - 54510

EP - 54516

JO - RSC advances

JF - RSC advances

SN - 2046-2069

ER -